The Effect of SuJok Application on Dysmenorrhea and Quality of Life in Young People With Primary Dysmenorrhea:

NCT06983600 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-03-17

No results posted yet for this study

Summary

Menarche, which is one of the most prominent features of maturation in adolescents and the transition from childhood to adulthood, causes many problems. The most prominent of these complaints is dysmenorrhea. Primary dysmenorrhea, the most common form of dysmenorrhea, is a gynecological disorder characterized by pain that starts in the lower abdomen before or during menstruation and radiates to the waist and legs.

Primary dysmenorrhea is seen especially in women under 25 years of age and within 6-12 months after menarche. Dysmenorrhea is a preventable and treatable disease. There are pharmacologic and nonpharmacologic methods in the treatment of dysmenorrhea. Pharmacologic methods include NSAIDs and hormonal contraceptives. Nonpharmacological methods used in the treatment of dysmenorrhea include hot application, regulation of nutrition, relaxation exercises, massage, yoga, reflexology, acupuncture, acupressure, TENS method, vitamins B and E, calcium, magnesium, zinc supplements, fennel and rose teas, ginger, aromotherapy applications. In addition to pharmacological methods, nonpharmacological methods are frequently used in the treatment of dysmeorrhea. People have recently turned to alternative medicine in the treatment of diseases in order to get rid of the side effects of drugs. Today, medicine is constantly developing and new treatment options are emerging. The treatment method that has recently started to be used and its effect has been seen is SuJok therapy. SuJok therapy was developed in 1986 by South Korean scientist Professor Park Jae Woo. In Korean, "Su" means hand and "Jok" means foot. In SuJok therapy, hands and feet are used as a treatment method. In SuJok, the hands and feet are a miniature replica of the body and have maximum structural similarity to the human body in anatomical terms. Every organ in our body has reflection points on the hands and feet. Thus, it activates all organs in our body with hands and feet. With the SuJok therapy method, it is argued that by using various techniques with the reflections of the body in the hand and foot points of the body, the organ and body area are physically stimulated and the energy in the body is activated and healing occurs. In the literature, studies on SuJok therapy applications are limited and there are no studies showing the effect of SuJok application on primary dysmenorrhea.

Conditions

  • Dysmenorrhea (Disorder)
  • Alternative Treatment

Interventions

OTHER

alternative therapy:sujok therapy

As of the first day of the menstrual period for a total of 10 days, the researcher will provide sensitization of the points and painful point detection with the ring and in-hand spiral in the hand macro insect and mini system. Then, moxa will be applied to the uterus and ovary reflection point between 2 minutes and 5 minutes. Moxa is a method that burns wormwood and treats it with the heat emitted to the skin by the smoke with perforated apparatus. It is one of the oldest treatment methods based on heat and plant healing. After the Moxa application, the black pepper seed will be fixed to the painful spot with the help of an air-tight plaster. The black pepper seed will be kept for at least 4 hours and maximum 8-10 hours.

Sponsors & Collaborators

  • Hasan Kalyoncu University

    collaborator OTHER
  • Muş Alparslan University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Months
Max Age
25 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-30
Primary Completion
2025-08-30
Completion
2025-08-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06983600 on ClinicalTrials.gov